Levilain; Guillaume

Patent Applications and Registrations

Patent applications and USPTO patent grants for Levilain; Guillaume.The latest application filed is for "prodrugs of substituted triazole derivatives and uses thereof".

Company Profile

3.8.6

Levilain; Guillaume - Wuppertal DE
Levilain; Guillaume - Deville des Rouen FR
Levilain; Guillaume - Deville les Rouen FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prodrugs of substituted triazole derivatives and uses thereof Grant 11,298,367 - Collin-Kroepelin , et al. April 12, 2	2022-04-12
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-1H-benzimidazole Grant 11,130,777 - Coquerel , et al. September 28, 2	2021-09-28
Prodrugs Of Substituted Triazole Derivatives And Uses Thereof App 20200338096 - COLLIN-KROEPELIN; Marie-Pierre ; et al.	2020-10-29
Crystalline Phases Of 5,6-dichloro-2-(isopropylamino)-(1-beta-l-ribofuranosyl)-1h-benzimidazole App 20190352326 - Coquerel; Gerard ; et al.	2019-11-21
Crystalline Phases Of 5,6-dichloro-2-(isopropylamino)-(1-beta-l-ribofuranosyl)-1h-benzimidazole App 20160304549 - Coquerel; Gerard ; et al.	2016-10-20
Process for the resolution of enantiomers by preferential evaporative crystallization Grant 8,907,106 - Coquerel , et al. December 9, 2	2014-12-09
Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization Grant 8,742,102 - Helmreich , et al. June 3, 2	2014-06-03
Crystalline Phases Of 5,6-dichloro-2-(isopropylamino)-(1- -l-ribofuranosyl)-1h-benzimidazole App 20130296542 - Coquerel; Gerard ; et al.	2013-11-07
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-.beta.-L-ribofuranosyl)-1H-benzimidazol- e Grant 8,546,344 - Coquerel , et al. October 1, 2	2013-10-01
Process For The Resolution Of Enantiomers By Preferential Evaporative Crystallization App 20120259127 - Coquerel; Gerard ; et al.	2012-10-11
Crystalline Phases Of 5,6-dfichloro-2-(isopropylamino)-1- -l-ribofuranosyl)-1h-benzimidazole App 20120178709 - Coquerel; Gerard ; et al.	2012-07-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.